Medical writing for rare diseases
Help make a difference in the lives of those with rare diseases! Our experienced team is dedicated to assisting you in sharing the success of your rare disease treatment through professional medical writing. With over 7,000 rare diseases out there, it's essential that we keep researching and innovating treatments.
Why do we specialise in rare diseases?
We are passionate about raising awareness about rare diseases, and we believe that they are unfairly overlooked by the medical community.
The more healthcare professionals are educated about rare diseases, the more likely patients are to receive an accurate and timely diagnosis, the right support, and possible treatments.
We hope that by creating informative materials that showcase your rare disease therapies, patients will receive a diagnosis sooner.
As a company, we are highly experienced at creating eye-catching and informative promotional materials regarding treatments for rare diseases. Our goal is to ensure that novel therapies reach those that need them as quickly and cost-efficiently as possible, and we believe this sets us apart from other companies who do not specialise in this therapeutic area.
Rare disease areas we explore
We have a particular interest in the following rare diseases:
- Cholangiocarcinoma
- Fabry disease
- Gaucher disease
- Hereditary angioedema
- Myelodysplastic syndromes
However, we are constantly developing our skills and expertise, and our interests are far and wide, meaning that the list doesn’t stop there!
History of rare diseases
The European Union defines a disease or condition as ‘rare’ if it affects fewer than 1 in 2,000 people within the general population.
Currently, there are ~7,000 known rare diseases worldwide, according to the National Institute of Health (NIH). Of these, ~95% have no treatment. However, a large number of rare diseases are still unknown as they are not being researched nor allocated funding, because the number of people affected is small compared to more “profitable” conditions, such as diabetes. In fact, rare diseases only receive about 1% of all funding from the 4 biggest funding bodies in the United Kingdom. Consequently, patients with rare diseases and their families often experience significant stress and uncertainty regarding diagnosis, prognosis, and treatment. On average, it takes 4 years for a patient to be diagnosed with a rare disease.
Although rare diseases affect far fewer people, they often manifest as very severe forms of common diseases and collectively affect a larger population, causing a devastating impact on their quality of life.
As well as promoting awareness of these diseases, and encouraging pharmaceutical companies and medical professionals to invest and conduct vital research, it is important that as medical writers, we support these initiatives and through our medical communications materials and regulatory submissions, advocate for the people who are living with these rare diseases.
The future of rare diseases
The future of rare diseases holds great promise, with more personalised treatments and approaches to care. Advances in expanding diagnostic procedures by improving sequencing methods will speed up the diagnosis of rare diseases.
Accepting agreed-upon nomenclature will aid in disease differentiation and identification of specific sub-populations of rare conditions. We anticipate product approvals will be made simpler by improved patient recruitment and more flexibility in the regulatory product review and approval process.
Looking for medical writers that specialise in rare diseases?
Whether it’s a new or existing treatment for a rare disease that you are researching and looking to raise awareness about, we can help you. Contact us through the form below and one of our team members will be in touch!
Contact us
Contact us using the details below and we can set up a video call to discuss your project needs and how we can help you.